FrancophonIA/ELRC3.0 huggingface dataset:
English: Intrinsa was expected to be used to treat HSDD in postmenopausal women with or without hormone treatment.
Slovenian: Zdravilo Intrinsa naj bi se uporabljalo za zdravljenje motnje hipoaktivne spolne želje pri ženskah po menopavzi, ki se ali se ne zdravijo s hormonsko terapijo.
English: There are no consequences on the use of Intrinsa in the treatment of HSDD in women who have had their womb and both ovaries removed.
Slovenian: Za zdravljenje žensk z motnjo hipoaktivne spolne želje, ki so jim odstranili maternico in oba jajčnika, glede uporabe zdravila Intrinsa ni posledic.
English: The company wanted the authorisation to be granted in Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Estonia, France, Germany, Italy, Latvia, Lithuania, Luxembourg, Norway, Poland, Portugal, Slovakia, Slovenia and Spain (the concerned Member States).
Slovenian: Družba je želela, da se dovoljenje odobri v Avstriji, Belgiji, Bolgariji, Češki republiki, na Danskem, v Estoniji, Franciji, Nemčiji, Italiji, Latviji, Litvi, Luksemburgu, na Norveškem, Poljskem, Portugalskem, Slovaškem, v Sloveniji in Španiji (zadevne države članice).
English: 1 Article 29 of Directive 2001/83/EC as amended, referral on the grounds of potential serious risk to public health
Slovenian: 1 Člen 29 Direktive 2001/83/ES, kot je bila spremenjena, o napotitvi na podlagi možnega resnega tveganja za javno zdravje.
English: Ref. EMEA/CHMP/191900/2009 EMEA/H/A-29/1096
Slovenian: : EMEA/189590/2009 EMEA/H/A-29/1096
English: As a result the cells cannot multiply.
Slovenian: Celice se posledično ne morejo več deliti.
English: The CHMP assessed the available data in order to establish whether the two indications can be supported.
Slovenian: Odbor CHMP je ovrednotil razpoložljive podatke, da bi ugotovil, ali je mogoče zadevni indikaciji podpreti.
English: The review was carried out under an ‘Article 29' referral1 procedure.
Slovenian: Pregled se je opravil v okviru napotitvenega postopka v skladu s členom 291.
English: Germany considered that the submitted data was insufficient for granting a marketing authorisation for the proposed indications.
Slovenian: Nemčija je menila, da predloženi podatki niso bili zadostni za odobritev dovoljenja za promet z zdravilom za predlagane indikacije.
English: Why was Bleomycin reviewed?
Slovenian: Zakaj je bilo zdravilo Bleomycin pregledano?
English: On 3 November 2008, the Netherlands medicines regulatory agency, the Medicines Evaluation Board, referred the matter to the CHMP.
Slovenian: Nizozemska regulatorna agencija za zdravila, Odbor za vrednotenje zdravil, je 3. novembra 2008 zadevo napotila na CHMP.
English: The RMS and the other positive CMSs were in favour of retaining these indications.
Slovenian: Referenčna država članica in druge pozitivne zadevne države članice so naklonjene ohranitvi teh indikacij.
English: The grounds for the referral were that Germany was not in a position to accept some of the anti-cancer indications because they were not recognised as acceptable for bleomycin in the country.
Slovenian: Razlogi za napotitev so bili, ker Nemčija ni mogla sprejeti nekaterih indikacij proti raku, saj jih ne priznava kot sprejemljive za bleomicin.
English: What is Bleomycin?
Slovenian: Kaj je zdravilo Bleomycin?
English: Questions and answers on the referral for Bleomycin, powder for solution for injection, 15 U/Vial, from Pharmachemie BV
Slovenian: Vprašanja in odgovori v zvezi z napotitvijo za zdravilo Bleomycin, prašek za raztopino za injiciranje, 15 e/vialo, družbe Pharmachemie BV
English: Bleomycin is an anti-cancer medicine used to treat certain forms of cancer of the head or the neck, cervix (the neck of the womb) and external sexual organs; certain forms of lymphoma (cancer of the lymphatic system) such as Hodgkin's disease; and to treat cancer of the testicles.
Slovenian: Bleomycin je zdravilo proti raku, ki se uporablja za zdravljenje določenih oblik raka glave ali vratu, cerviksa (materničnega vratu) in zunanjih spolovil, nekaterih oblik limfoma (raka limfnega sistema), kot je Hodgkinova bolezen, ter raka testisov.
English: The indications ‘head and neck carcinoma' and ‘epidermoid carcinoma of external genitalia such as penile carcinoma, or cervix' had been deleted from the authorised indications for all bleomycin-containing products in Germany because the balance of benefit/risk for bleomycin in these indications was considered negative.
Slovenian: Indikaciji „karcinom glave in vratu“ ter „epidermoidni karcinom zunanjih spolovil, kot je karcinom penisa ali cerviksa“, sta bili v Nemčiji izbrisani iz odobrenih indikacij za vsa zdravila, ki vsebujejo bleomicin, ker se je menilo, da je razmerje med koristmi in tveganji za bleomicin pri teh indikacijah negativno.
English: Bleomycin is almost always used in combination with anti-cancer drugs or in combination with radiation.
Slovenian: Zdravilo Bleomycin se skoraj vedno uporablja v kombinaciji z zdravili proti raku ali z obsevanjem.
English: The European Medicines Agency (EMEA) has completed a referral procedure following a disagreement among Member States of the European Union regarding the authorisation of the medicine Bleomycin injection, from Pharmachemie BV.
Slovenian: Evropska agencija za zdravila (EMEA) je končala napotitveni postopek, do katerega je prišlo po nesoglasju med državami članicami Evropske unije glede odobritve zdravila Bleomycin, injekcija, družbe Pharmachemie BV.
English: Pharmachemie BV submitted a Marketing Authorisation Application for Bleomycin powder for solution for injection 15 U/vial in the decentralised procedure on 10 July 2007, the Netherlands acting as the reference member state.
Slovenian: Družba Pharmachemie BV je vlogo za pridobitev dovoljenja za promet z zdravilom Bleomycin, prašek za raztopino za injiciranje, 15 e/vialo, predložila po decentraliziranem postopku dne 10. julija 2007, pri tem pa je Nizozemska prevzela vlogo referenčne države članice.
English: Based on evaluation of the currently available data, including published literature and current treatment guidelines, and the scientific discussion within the Committee, the CHMP concluded that the benefits of Bleomycin injection, from Pharmachemie BV, outweigh its risks, and therefore the marketing authorisation for Bleomycin should be granted in all concerned member states.
Slovenian: Na podlagi vrednotenja trenutno razpoložljivih podatkov, vključno z objavljeno literaturo in trenutno veljavnimi smernicami za zdravljenje, ter znanstvene razprave znotraj CHMP je ta zaključil, da koristi zdravila Bleomycin, injekcija, družbe Pharmachemie BV odtehtajo njegova tveganja ter da je zato treba dovoljenje za promet z zdravilom Bleomycin odobriti v vseh zadevnih državah članicah.
English: Bleomycin can also be used by injection directly inside the chest cavity to treat fluid accumulation in the lungs as a result of cancer.
Slovenian: Zdravilo Bleomycin se lahko injicira neposredno v prsno votlino za zdravljenje pojava tekočine, ki se v pljučih nabira kot posledica raka.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefits of Bleomycin injection, from Pharmachemie BV, outweigh its risks, and the marketing authorisation can be granted in the Member States of the European Union and the European Economic Area.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji EMEA je zaključil, da koristi zdravila Bleomycin, injekcija, družbe Pharmachemie BV odtehtajo njegova tveganja in da se dovoljenje za promet z zdravilom lahko odobri v državah članicah Evropske unije in Evropskega gospodarskega prostora.
English: Referral start date:
Slovenian: Datum začetka postopka napotitve: 20. november 2008 Datum izdaje mnenja:
English: Bleomycin inserts itself within the strands of DNA, the genetic material of cells, making the strands break.
Slovenian: Zdravilo Bleomycin se vrine v verige DNK, tj. genetsko gradivo celice, ki se začne zaradi zdravila trgati.
English: Because consensus could not be reached, the procedure was
Slovenian: Postopek je bil napoten na odbor CHMP, ker ni bilo mogoče doseči soglasja.
English: Bleomycin is a cytostatic substance; this means that it stops the growth of cells.
Slovenian: Zdravilo Bleomycin je citostatična spojina.
English: 40 IU/ml Solution for injection
Slovenian: raztopina za injiciranje raztopina za injiciranje
English: London, September 2008 EMEA/436209/2008
Slovenian: London, 26.09.2008 EMEA/436209/2008
English: EMEA/436209/2008
Slovenian: EMEA/436209/2008-SL
English: • The benefit/risk balance of the product was shown to be positive, however in young animals, the summary of Product Characteristics should state that the product is not to be used in neonates or very young calves of less than 2 weeks of age nor in piglets of less than 4 weeks of age.
Slovenian: • Razmerje med koristmi in tveganji se je pokazalo kot pozitivno, kljub temu pa je v povzetku glavnih značilnosti zdravila za uporabo pri mladih živalih potrebno navesti, da zdravilo ni namenjeno uporabi pri komaj skotenih ali zelo mladih teletih, starih manj kot dva tedna, ter pri pujskih, starih manj kot štiri tedne.
English: The CVMP Opinion was adopted on 16 July 2008 and the subsequent Commission Decision adopted on 26 September 2008.
Slovenian: Mnenje Odbora za zdravila za uporabo v veterinarski medicini (CVMP) je bilo sprejeto 16.07.2008 odločba Komisije pa 26.09.2008.
English: OPINION FOLLOWING AN ARTICLE 35 REFERRAL FOR SODIUM SALICYLATE
Slovenian: ODBOR ZA ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI (CVMP) MNENJE V ZVEZI Z NAPOTITVIJO V SKLADU S ČLENOM 35 ZA ZDRAVILO NATRIJEV SALICILAT
English: --1Live attenuated bovine respiratory syncytial virus (BRSV), strain Lym-56 104.7 - 6.5 CCID50* *Cell culture infectious dose 50%
Slovenian: --1 živ oslabljen bovini respiratorni sincicijski virus (BRSV), sev Lym-56 104,7-6,5 CCID50* * 50-% infektivni odmerek v celični kulturi
English: Immediate packaging
Slovenian: Način uporabe Pakiranje za takojšnjo uporabo
English: Package size Withdraw al period
Slovenian: Velikost pakiranja
English: Intravenous use vial (glass)
Slovenian: 4,5 mg/ml koncentrat za raztopino za infundiranje intravenska uporaba viala (steklena)
English: (Invented) name Strength Pharmaceutical Form Route of Administration
Slovenian: Številka EU (Izmišljeno) ime Jakost
English: hours before taking the other.
Slovenian: 3 ure, preden vzamete drugo.
English: Date of first authorisation: 16 September 1998 Date of latest renewal: 3 September 2008
Slovenian: Datum prve odobritve: 16. september 1998 Datum zadnjega podaljšanja: 3. september 2008
English: After taking one of them, wait at least 2 to 3
Slovenian: Po zaužitju enega od teh zdravil počakajte vsaj 2 do
English: Comtess and iron supplements at the same time.
Slovenian: Comtess in dodatkov železa istočasno.
English: • binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger).
Slovenian: • prenajedanje (uživanje velikih količin hrane v kratkem času) ali kompulzivno prenajedanje (uživanje večjih količin hrane kot običajno oziroma več, kot je potrebno za potešitev lakote).
English: • altered or increased sexual interest and behaviour of significant concern to you or to others, for example, an increased sexual drive;
Slovenian: • spremenjeno ali povečano zanimanje za spolnost in zaskrbljujoče spolno vedenje, na primer povečano spolno slo;
English: • if you are taking certain antidepressants (ask your doctor or pharmacist whether your antidepressive medicine can be taken together with Comtess);
Slovenian: • če jemljete določene antidepresive (povprašajte svojega zdravnika ali farmacevta, ali lahko jemljete svoje zdravilo proti depresiji skupaj z zdravilom Comtess);
English: What Comtess is and what it is used for
Slovenian: Kaj je zdravilo Comtess in za kaj ga uporabljamo
English: EU/1/98/082/001 30 film-coated tablets EU/1/98/082/002 60 film-coated tablets EU/1/98/082/003 100 film-coated tablets EU/1/98/082/005 175 film-coated tablets
Slovenian: EU/1/98/082/001 30 filmsko obloženih tablet EU/1/98/082/002 60 filmsko obloženih tablet EU/1/98/082/003 100 filmsko obloženih tablet EU/1/98/082/005 175 filmsko obloženih tablet
English: The safety and efficacy of Comtess in children below age 18 have not been established.
Slovenian: Varnost in učinkovitost zdravila Comtess pri otrocih, starih do 18 let, nista bili dokazani.
English: If you stop taking Comtess Do not stop taking Comtess unless your doctor tells you to.
Slovenian: Če ste prenehali jemati zdravilo Comtess Ne prekinite jemanja zdravila Comtess, razen če vam to naroči vaš zdravnik.
English: Do not use Comtess during pregnancy or if you are breast-feeding.
Slovenian: Ne jemljite zdravila Comtess v nosečnosti ali če dojite.
English: If you experience such effects at the start of treatment with Comtess you should contact your doctor who may decide to adjust your dosage of levodopa.
Slovenian: Če pri vas pride od takih učinkov na začetku zdravljenja z zdravilom Comtess, morate obvestiti zdravnika, ki se bo morda odločil, da vam prilagodi odmerjanje levodope.
English: Other medicines and Comtess
Slovenian: Druga zdravila in zdravilo Comtess
English: What you need to know before you take Comtess
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Comtess
English: There are large intra- and interindividual variations in the absorption of entacapone.
Slovenian: V absorpciji entakapona so velike intra- in interindividualne variacije.
English: If you forget to take Comtess
Slovenian: Če ste pozabili vzeti zdravilo Comtess
English: Comtess in association with levodopa may have a major influence on the ability to drive and use machines.
Slovenian: Comtess ima skupaj z levodopo pomemben vpliv na sposobnost vožnje in upravljanja s stroji.
English: Do not take Comtess
Slovenian: Ne jemljite zdravila Comtess
English: What Comtess is and what it is used for What you need to know before you take Comtess How to take Comtess
Slovenian: Kaj je zdravilo Comtess in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Comtess Kako jemati zdravilo Comtess Možni neželeni učinki
English: If you forget to take the Comtess tablet with your levodopa dose, you should continue the treatment by taking the next Comtess tablet with your next levodopa dose.
Slovenian: Če pozabite vzeti tableto Comtess s svojim odmerkom levodope, nadaljujte zdravljenje tako, da vzamete naslednjo tableto Comtess z naslednjim odmerkom levodope.
English: White high-density polyethylene (HDPE) bottles with white tamper proof polypropylene (PP) closures containing 30, 60, 100 or 175 tablets.
Slovenian: Bele stekleničke iz polietilena visoke gostote (HDPE), z belim polipropilenskim (PP) pokrovčkom, odpornim proti nepooblaščenemu odpiranju, v katerih je po 30, 60, 100 ali 175 tablet.
English: When Comtess is given at higher doses:
Slovenian: Pri uporabi višjih odmerkov zdravila Comtess:
English: comtess 200 mg [carton only]
Slovenian: comtess 200 mg [samo na škatli]
English: If you take more Comtess than you should In the event of an overdose, consult your doctor, pharmacist or the nearest hospital immediately.
Slovenian: Če ste vzeli večji odmerek zdravila Comtess, kot bi smeli Če ste vzeli prevelik odmerek, se takoj posvetujte z zdravnikom, farmacevtom ali najbližjo bolnišnico.
English: • dizziness, tiredness, increased sweating, fall ;
Slovenian: • omotičnost, utrujenost, povečano znojenje, padec;
English: General characteristics of the active substance Absorption
Slovenian: Splošne značilnosti zdravilne učinkovine Absorpcija
English: Comtess may make it harder for you to digest iron.
Slovenian: Zdravilo Comtess lahko oteži prebavljanje železa.
English: As Comtess tablets will be taken together with other levodopa medicines, please also read the package leaflets of these medicines carefully.
Slovenian: Ker boste tablete Comtess jemali skupaj z drugimi zdravili z levodopo, skrbno preberite tudi njihova navodila za uporabo.
English: Comtess tablets contain entacapone and are used together with levodopa to treat Parkinson's disease.
Slovenian: Tablete Comtess vsebujejo entakapon in jih uporabljamo skupaj z levodopo za zdravljenje Parkinsonove bolezni.
English: The recommended dose of Comtess is one 200 mg tablet with each levodopa dose.
Slovenian: Priporočeni odmerek zdravila Comtess je ena 200-miligramska tableta z vsakim odmerkom levodope.
English: Suddenly stopping Comtess and other medicines to treat Parkinson´s disease may result in unwanted side effects.
Slovenian: Nenadna prekinitev zdravljenja z zdravilom Comtess in drugimi zdravili za Parkinsonovo bolezen lahko povzroči neželene učinke.
English: Comtess is taken together with medicines containing levodopa (either levodopa/carbidopa preparations or levodopa/benserazide preparations).
Slovenian: Zdravilo Comtess se jemlje skupaj z zdravili, ki vsebujejo levodopo (bodisi pripravki levodope/karbidope bodisi pripravki levodope/benserazida).
English: Comtess has no effect on relieving the symptoms of Parkinson's disease unless taken with levodopa.
Slovenian: Zdravilo Comtess ne lajša simptomov Parkinsonove bolezni, če ga bolnik ne vzame skupaj z levodopo.
English: Usually side effects caused by Comtess are mild to moderate.
Slovenian: Neželeni učinki, ki jih povzroča zdravilo Comtess, so navadno blagi do zmerni.
English: Comtess aids levodopa in relieving the symptoms of Parkinson's disease.
Slovenian: Zdravilo Comtess pomaga levodopi pri lajšanju simptomov Parkinsonove bolezni.
English: How to take Comtess
Slovenian: Kako jemati zdravilo Comtess
English: What Comtess contains - The active substance is entacapone.
Slovenian: Kaj vsebuje zdravilo Comtess - Zdravilna učinkovina je entakapon.
English: Your doctor may advise you to slowly discontinue the treatment with Comtess and other medicines to treat Parkinson's disease.
Slovenian: Zdravnik vam bo morda svetoval, da zdravilo Comtess in druga zdravila za Parkinsonovo bolezen prenehate jemati postopoma.
English: However, the experience of the clinical use of entacapone with several medicinal products, including MAO-A inhibitors, tricyclic antidepressants, noradrenaline reuptake inhibitors such as desipramine, maprotiline and venlafaxine, and medicinal products that are metabolised by COMT (e.g. catecholstructured compounds: rimiterole, isoprenaline, adrenaline, noradrenaline, dopamine, dobutamine,
Slovenian: Vendar so izkušnje s klinično uporabo entakapona z več zdravili, med drugim z zaviralci MAO-A, tricikličnimi antidepresivi, zaviralci ponovnega privzema noradrenalina, kot so desipramin, maprotilin in venlafaksin, in zdravili, ki jih presnavlja COMT (na primer spojine s kateholno skupino: rimiterol, izoprenalin, adrenalin, noradrenalin, dopamin, dobutamin, alfa-metildopa, apomorfin in paroksetin), še omejene.
English: In addition, Comtess taken with levodopa may make you feel very drowsy, or cause you to sometimes suddenly fall asleep.
Slovenian: Poleg tega lahko zdravilo Comtess, ki ga vzamete skupaj z levodopo, povzroči hudo zaspanost ali povzroči, da včasih nenadoma zaspite.
English: Comtess 200 mg film-coated tablets
Slovenian: Comtess 200 mg filmsko obložene tablete
English: • Comtess taken with levodopa may rarely make you feel very drowsy during the day, and cause you to suddenly fall asleep;
Slovenian: • poredko se lahko zgodi, da zaradi zdravila Comtess, ki ga jemljete z levodopo, postanete čez dan izredno zaspani, lahko tudi povzroči, da nenadoma zaspite;
English: Comtess taken together with levodopa may lower your blood pressure, which may make you feel light-headed or dizzy.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Zdravilo Comtess, ki ga jemljete skupaj z levodopo, vam lahko zniža krvni tlak, zaradi česar se vam lahko stemni pred očmi ali postanete omotični.
English: Comtess contains soya lecithin.
Slovenian: Zdravilo Comtess vsebuje sojin lecitin
English: Talk to your doctor or pharmacist before taking Comtess:
Slovenian: Pred začetkom jemanja zdravila Comtess se posvetujte z zdravnikom ali farmacevtom:
English: What Comtess looks like and contents of the pack Comtess 200 mg film-coated tablets are brownish-orange, oval tablets with "COMT" engraved on one side.
Slovenian: Comtess 200 mg filmsko obložene tablete so rjavkastooranžne, ovalne tablete z vtisnjenim napisom “COMT” na eni strani.
English: Impulse control disorders: Pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists and/or other dopaminergic treatments such as Comtess in association with levodopa (see section 4.4).
Slovenian: Motnje pri obvladovanju impulzov: Pri bolnikih, ki se zdravijo z agonisti dopamina in/ali drugimi dopaminergičnimi zdravili, kot je zdravilo Comtess v povezavi z levodopo, lahko pride do patološkega hazardiranja, povečanega libida, hiperseksualnosti, kompulzivnega zapravljanja ali nakupovanja, prenajedanja ali kompulzivnega prenajedanja (glejte poglavje 4.4).
English: Comtess taken with levodopa may cause drowsiness and may cause you to sometimes suddenly fall asleep.
Slovenian: Zdravilo Comtess, ki ga vzamete skupaj z levodopo, lahko povzroča zaspanost ali povzroči, da včasih nenadoma zaspite.
English: Comtess 200 mg film-coated tablets entacapone
Slovenian: Comtess 200 mg filmsko obložene tablete entakapon
English: Patients and carers should be made aware that behavioural symptoms of impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists and/or other dopaminergic treatments such as Comtess in association with levodopa.
Slovenian: Bolnike in njihove skrbnike je treba opozoriti, da pri bolnikih, ki se zdravijo z agonisti dopamina in/ali drugimi dopaminergičnimi zdravili, kot je zdravilo Comtess v povezavi z levodopo, lahko pride do vedenjskih simptomov, ki so znak motenj pri obvladovanju impulzov, kar vključuje patološko hazardiranje, povečan libido, hiperseksualnost, kompulzivno zapravljanje ali nakupovanje, prenajedanje in kompulzivno prenajedanje.
English: The maximum recommended dose is 10 tablets per day, i.e. 2,000 mg of Comtess.
Slovenian: Najvišji priporočeni odmerek je 10 tablet na dan, t.j.
English: Experience with Comtess in patients under 18 years is limited.
Slovenian: Izkušenj z uporabo zdravila Comtess pri bolnikih, ki so stari manj kot 18 let, je malo, zato uporabe zdravila Comtess pri otrocih in mladostnikih ni mogoče priporočati.
English: How to store Comtess
Slovenian: Shranjevanje zdravila Comtess
English: Neuroleptic Malignant Syndrome (NMS) is a serious but rare reaction to certain medicines, and may occur especially when Comtess and other medicines to treat Parkinson's disease are suddenly stopped or the dose is suddenly reduced.
Slovenian: Do nje lahko pride zlasti pri nenadni prekinitvi zdravljenja z zdravilom Comtess in drugimi zdravili za Parkinsonovo bolezen oziroma pri nenadnem znižanju odmerka teh zdravil.
English: The dose of other medicines to treat Parkinson's disease may need to be adjusted when you start taking Comtess.
Slovenian: Morda bo ob uvedbi zdravila Comtess potrebno prilagoditi odmerke drugih zdravil za Parkinsonovo bolezen.
English: 3 years
Slovenian: 3 let
English: This dosage may be continued for up to thirteen weeks.
Slovenian: S tem odmerkom se lahko nadaljuje do trinajst tednov.
English: Terminal half life (t½) is 3.5-4 hours.
Slovenian: Končna razpolovna doba (t½) je 3,5-4 ure.
English: Patients were re-randomised at 3 weeks.
Slovenian: Bolniki so bili pri 3 tednih ponovno randomizirani.
English: These medicines include:
Slovenian: Med ta zdravila spadajo:
English: - If you have been told you suffer from an autoimmune disease (where the body is ‘attacked' by its own immune system).
Slovenian: • če so vam povedali, da imate avtoimunsko bolezen (kjer telo »napada« njegov lastni imunski sistem).
English: • Presence of red blood cells in the urine
Slovenian: • prisotnost rdečih krvničk v urinu
English: The clinical relevance of the finding is unknown.
Slovenian: Klinični pomen te ugotovitve ni znan.